- Exchange: London
- Sector: Technology
- Industry: Software
- Sub-Industry: Applications Software
Snapshot for Instem PLC (INS)
| Open: | 162.5000 | Day's Range: | 162.5000 - 162.5000 | Volume: | 0 | Bid: | 158.0000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 162.5000 | 52wk Range: | 159.0000 - 234.0000 | 1-Yr Rtn: | -27.29% | Ask: | 167.0000 |
Key Statistics for INS
| Current P/E Ratio (ttm) | 18.9218 |
|---|---|
| Estimated P/E (12/2012) | 13.3197 |
| Earnings Per Share (GBP) (ttm) | 0.0859 |
| Est. EPS (GBP) (12/2012) | 0.1220 |
| Est. PEG Ratio | - |
| Market Cap (M GBP) | 19.12 |
| Shares Outstanding (M) | 11.76 |
| Enterprise Value (M GBP) (ttm) | 16.00 |
| Enterprise Value/EBITDA (ttm) | 7.88 |
| Price/Book (mrq) | 3.5160 |
| Price/Sale (ttm) | 1.7637 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 09/21/2012 |
More INS Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for INS
- Operating
- Investing
- Financing (M/GBP)
Company Profile & Key Executives for INS
Instem PLC provides information technology applications to the global early development healthcare market. The Group is focused on the early development sector of the drug and chemical research and development industry, from late discovery and lead optimisation through to the Phase I clinical evaluation stage.
| David GareChairman | Philip John Reason "Phil"Chief Executive Officer |
| Nigel J GoldsmithChief Financial Officer | Michael Harwood "Mike"Senior VP:Toxicology & Path |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page